Cancer Incidence After Retinoblastoma
- 15 October 1997
- journal article
- research article
- Published by American Medical Association (AMA) in Jama-Journal Of The American Medical Association
- Vol. 278 (15), 1262-1267
- https://doi.org/10.1001/jama.1997.03550150066037
Abstract
Context. —There is a substantial risk of a second cancer for persons with hereditary retinoblastoma, which is enhanced by radiotherapy. Objective. —To examine long-term risk of new primary cancers in survivors of childhood retinoblastoma and quantify the role of radiotherapy in sarcoma development. Design. —Cohort incidence study of patients with retinoblastoma followed for a median of 20 years, and nested case-control study of a radiation dose-response relationship for bone and soft tissue sarcomas. Setting/Participants. —A total of 1604 patients with retinoblastoma who survived at least 1 year after diagnosis, identified from hospital records in Massachusetts and New York during 1914 to 1984. Results. —Incidence of subsequent cancers was statistically significantly elevated only in the 961 patients with hereditary retinoblastoma, in whom 190 cancers were diagnosed, vs 6.3 expected in the general population (relative risk [RR], 30 [95% confidence interval, 26-47]). Cumulative incidence (±SE) of a second cancer at 50 years after diagnosis was 51.0% (±6.2%) for hereditary retinoblastoma, and 5.0% (±3.0%) for nonhereditary retinoblastoma. All 114 sarcomas of diverse histologic types occurred in patients with hereditary retinoblastoma. For soft tissue sarcomas, the RRs showed a stepwise increase at all dose categories, and were statistically significant at 10 to 29.9 Gy and 30 to 59.9 Gy. A radiation risk for all sarcomas combined was evident at doses above 5 Gy, rising to 10.7-fold at doses of 60 Gy or greater (P<.05). Conclusions.— Genetic predisposition has a substantial impact on risk of subsequent cancers in retinoblastoma patients, which is further increased by radiation treatment. A radiation dose-response relationship is demonstrated for all sarcomas and, for the first time in humans, for soft tissue sarcomas. Retinoblastoma patients should be examined for new cancers and followed into later life to determine whether their extraordinary cancer risk extends to common cancers of adulthood.Keywords
This publication has 12 references indexed in Scilit:
- Sinonasal primitive neuroectodermal tumor arising in a long-term survivor of heritable unilateral retinoblastomaCancer, 1992
- Tissue doses from radiotherapy of cancer of the uterine cervixMedical Physics, 1989
- Seven Cases of Trilateral RetinoblastomaAmerican Journal of Ophthalmology, 1989
- Incidence of Second Neoplasms in Patients with Bilateral RetinoblastomaOphthalmology, 1988
- Risk of nonocular cancer among retinoblastoma patients and their parents: A population-based study in Denmark, 1943–1984Cancer, 1988
- Cutaneous Malignant Melanoma in Survivors of Heritable RetinoblastomaAmerican Journal of Ophthalmology, 1988
- Clinical Aspects of Postirradiation Sarcomas1JNCI Journal of the National Cancer Institute, 1988
- Cancer incidence, survival, and mortality for children younger than age 15 yearsCancer, 1986
- Second primary neoplasms in patients with retinoblastomaBritish Journal of Cancer, 1986
- Late Extraocular Tumours in Retinoblastoma SurvivorsOphthalmologica, 1980